StonvexLoading…
StonvexStonvexStonvexCore line items from RBBN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $194.61M | $162.61M | $844.56M | $617.23M | $401.86M |
Operating Income | Not available | $-31.70M | $-3.32M | $-12.62M | $-15.38M |
Net Income | Not available | $-34.49M | $39.64M | $-49.43M | $-37.32M |
EPS (Diluted) | $-0.01 | $-0.20 | $0.22 | $-0.28 | $-0.21 |
Total Assets | Not available | $1.16B | $1.21B | $1.11B | $1.14B |
Total Liabilities | Not available | $740.60M | $763.26M | $745.18M | $771.74M |
Cash & Equivalents | Not available | $67.55M | $96.41M | $74.80M | $60.45M |
Free Cash Flow OCF − CapEx | Not available | $-25.07M | $26.06M | $-1.21M | $-22.16M |
Shares Outstanding | Not available | 175.51M | 175.78M | 176.48M | 177.16M |